Pallas Health vs Embody: clinician choice vs low-cost compounded GLP-1
Quick verdict: Pallas Health vs Embody
Pallas Health and Embody both provide online clinician-reviewed GLP-1 programs, but they target different priorities. Early verdict: choose Embody for the lowest compounded semaglutide entry price and fast 1–2 day shipping; choose Pallas Health if you want a clinician to pick between FDA-approved brand-name pens and a US-compounded alternative, with an all-in plan price that includes provider care.
How they differ: 3 distinctive comparison areas
This comparison focuses on the most distinctive supported differences: medication options and brand availability, pricing structure and billing cadence, and delivery plus program features including clinician role and included care.
1) Medication options and clinician choice
Pallas Health supports both FDA-approved brand-name GLP-1s (Wegovy, Ozempic, Zepbound and Mounjaro) and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Embody offers compounded semaglutide and compounded tirzepatide only; the evidence states it does not offer branded Ozempic, Wegovy or Zepbound.
2) Pricing structure and renewal cadence
Pallas Health lists compounded semaglutide at $139 for the first month then $597 every 12 weeks, a $199 per month average; compounded tirzepatide is $179 first month then $897 every 12 weeks, a $299 per month average. Pallas also publishes cash-pay brand-name prices for Wegovy, Zepbound, Ozempic and Mounjaro as shown on its site. Pallas prices compounded plans by medication rather than by milligram, so titration does not raise the plan price, and provider care is included with no membership fee.
Get Embody pricing and shipping
Embody advertises a lower entry point for compounded semaglutide: $69 per month (presented as cut from $299) and $119 per month for compounded tirzepatide, with flat monthly pricing and no membership. Embody emphasizes the $69/month offer as a limited-time price that may increase and notes final pricing may vary based on dose and clinician recommendation.
3) Delivery, access and included services
Embody promises free shipping and delivery in 1–2 days after clinician approval and positions itself as a lean, no-frills prescription-forward model with telehealth visits included and cancel-anytime flexibility. Embody also notes 24/7 support access for dosing and side-effect questions.
Pallas Health provides free expedited and discreet shipping on every plan and an all-in plan price that includes clinician review, ongoing check-ins and care-team messaging. Pallas is 100% online and asynchronous in most states, though a video visit is required in seven states plus Washington, D.C. Pallas also states care-team hours are weekdays 9 AM to 5 PM ET and that it does not offer emergency services.
Comparison table: Pallas Health vs Embody
| Criteria | Pallas Health | Embody |
|---|---|---|
| Medication options | FDA-approved Wegovy, Ozempic, Zepbound, Mounjaro and US-compounded semaglutide/tirzepatide | Compounded semaglutide and tirzepatide only |
| Starting price (compounded semaglutide) | $139 first month, then $597 every 12 weeks ($199/mo avg) | $69/month (promoted as cut from $299) |
| Billing cadence | Compounded plans renew every 12 weeks; brand-name listed as monthly cash-pay | Flat locked-in monthly pricing |
| Shipping speed | Free expedited shipping, discreet | Free shipping, arrives in 1–2 days after approval |
| Included clinician care | Provider care, check-ins and messaging included in plan price; eligibility determined by US-licensed clinician | Prescription and telemed visits included; licensed provider review online |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Other points from the evidence
Pallas notes it does not manufacture or compound medication; compounded medications are prepared by US-licensed compounding pharmacies and the medication you receive may differ in appearance from any product shown. Pallas is cash-pay only and does not bill insurance; FSA/HSA use needs a Letter of Medical Necessity. Embody is also direct-pay and does not take insurance, and it frames the $69 price as a limited-time offer.
Conclusion: choose based on priorities
When weighing Pallas Health vs Embody, the choice comes down to whether you prioritize brand access and clinician-led option selection or the lowest advertised compounded price and fastest shipping. Both use licensed clinician reviews and both rely on compounded medication options that are not FDA-approved where applicable.
Choose Pallas Health if…
- You want a clinician to choose between FDA-approved brand-name pens and a US-compounded alternative.
- You prefer an all-in plan price that includes provider care, check-ins and messaging with no membership fee.
- You value pricing that does not increase with titration because compounded plans are priced by medication rather than by milligram.
Choose Embody if…
- Your main priority is the lowest advertised compounded semaglutide entry price at $69/month and fast 1–2 day shipping after approval.
- You want a straightforward, no-frills monthly price with telehealth visits included and cancel-anytime flexibility.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →